the market?
Sanofi (ADR)
NYSE: SNY
53.84
-0.66
(-1.21%)
| Today's Open | $54.14 |
|---|---|
| Previous Close | $54.50 |
| Daily Range | $53.84 - $54.40 |
| 52-Week Range | $33.03 - $55.77 |
| Market Cap | $144.4B |
| P/E Ratio | 29.30 |
| Dividend (Yield) | $1.30 (2.4%) |
| Ex-Dividend Date Dividend Pay Date |
05/06/13 01/01/70 |
| Volume | 972,253 |
| Average Daily Volume | 2,444,214 |
| Current FY EPS | $3.75 |
How do you think SNY
will perform against the market?
Top SNY Bull/Bear Pitches
CraigMiles (< 20)
Submitted
October 30, 2011
Undervalued plus ~3% to 4% dividend.<br />The value has been tricky to estimate as the company has so much equity. If I only consider the present value of the ability to generate FCF I get a value of … More
News & Commentary
1 Great Dividend You Can Buy Right Now
This stocks yield may not be a jaw-dropper yet, but it's positioned "purrrrrfectly" in a rapidly growing sector to deliver long term profits and payouts.Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Glo
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.Will ASCO Unlock Big Value in This Cancer Drug Class?
With the American Society of Clinical Oncology's annual meeting less than two weeks away, see what drug class could see big gains in the wake of new abstract data.Sector
Healthcare
Industry
Drugs
Sanofi (ADR) (SNY) Description
A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website: http://www.sanofi-aventis.com/
CEO Rating by Glassdoor
More details for Sanofi-Aventis Jobs
Sanofi-Aventis reviews from employees
